Evidence map›Paper›PMID 40402247›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Multiparametric functional characterization of individual lipid nanoparticles using surface-sensitive light-scattering microscopy.

Mattias Sjöberg, Erik Olsén, Mokhtar Mapar, Petteri Parkkila, Simon Niederkofler, Sara Mohammadi, Yujia Jing, Gustav Emilsson, Lennart Lindfors, Björn Agnarsson and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Multiparametric functional characterization of individual lipid nanoparticles using surface-sensitive light-scattering microscopy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mattias SjöbergDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.ORCID 0000-0003-3753-2564
Erik OlsénDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.ORCID 0000-0002-4002-0917
Mokhtar MaparDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.
Petteri ParkkilaDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.ORCID 0000-0002-2717-0232
Simon NiederkoflerDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.
Sara MohammadiDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.
Yujia JingAdvanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.
Gustav EmilssonAdvanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.ORCID 0000-0002-5030-3953
Lennart LindforsAdvanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg 431 83, Sweden.ORCID 0000-0002-6711-0605
Björn AgnarssonDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.ORCID 0000-0003-3364-7196
Fredrik HöökDivision of Nano and Biophysics, Department of Physics, Chalmers University of Technology, Gothenburg 412 96, Sweden.ORCID 0000-0003-1994-5015

Funding

Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) 2019-0577Stiftelsen för Strategisk Forskning (SSF) IRC15-0065Vetenskapsrådet (VR) 2022-05016
6 · The paper itself

Abstract

The most efficient lipid nanoparticles (LNPs) for gene therapeutics rely on specific lipids that protect the oligonucleotide cargo and aid cellular uptake and subsequent endosomal escape. Yet, the efficacy of current state-of-the-art LNP formulations remains low, a few percent at best. A deeper understanding of how LNP cargo, lipid composition, stoichiometry, size, structure, and pH-induced conformational changes influence their efficiency is therefore necessary for improved design. Given the variability of these properties, preferred screening methods should offer single-particle-resolved multiparametric characterization. In this work, we employ combined surface-sensitive fluorescence and label-free scattering microscopy with single LNP resolution, which when integrated with microfluidics for liquid exchange between media of varying refractive index, enables quantification of LNP size, refractive index, and cargo content. We investigate two LNP formulations that, while similar in size and mRNA content, exhibit differences in functional mRNA delivery. Correlating size with the content of Cy5-labeled mRNA revealed that the cargo scaled with LNP volume for both types of LNPs, while the refractive index varied marginally across LNP size. While this multiparametric fingerprinting alone could not distinguish the two LNP formulations, we use the same experimental platform to show that their difference in fusogenicity to a supporting lipid bilayer under early endosomal conditions (drop in pH from 7.4 to 6.0) correlates with observed differences in in vitro cellular data. This highlights a limitation of the current state-of-the-art toolbox for in situ LNP characterization, which generally focuses on structural properties of suspended LNPs, which may not adequately capture functional performance.

Indexed as

LipidsMicroscopyNanoparticlesHumansLightLiposomesRNA, MessengerScattering, RadiationLipid NanoparticlesLipidsLiposomesRNA, Messengerfluorescencelight scatteringlipid nanoparticlesmRNAoptical microscopy

Identifiers

PMID40402247
PMCPMC12130878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.